Georgia Society of Health-SystemPharmacistsOur mission is to help our members become better practitioners. |
Summer meeting cancelled
After thoughtful consideration, the GSHP leadership has made the decision to cancel our GSHP Summer Meeting that was set to take place July 9-12 at the Omni Amelia Island Plantation Resort. We have been closely monitoring the information and recommendations from the Centers for Disease Control (CDC), as well as state and local governments, related to COVID-19. Based on the continued uncertainty around the safety of large gatherings and travel restrictions for our attendees, we feel the most appropriate course of action at this point is to cancel our meeting.
Our Summer Meeting is an annual highlight for our attendees and families and a time to celebrate our achievements over the past year. We are disappointed that we will miss another opportunity for education and networking with each other, but we are working on alternate ways to highlight our awards winners, new officer installation, and Reverse Expo. Despite these uncertain times, GSHP remains committed to our members. In particular, I would like to highlight two efforts. First, our District Directors and Education Committee, led by Lindsay Schaak Rothstein and John Patka, recognize that our members rely on the high quality continuing education provided by GSHP through our local and state meetings. Hopefully you have been one of the many participants that have been able to access this increased quantity and variety of time offerings of our live webinars. Second, our Director of Pharmacy and Clinical Conference Calls have been critical as we navigate this pandemic together by providing an avenue for our health-system partners around the state to share ideas, concerns, and lessons learned in real time.
Thank you for your continued patience during this difficult time.
If you have a reservation in the GSHP room block, the Omni will
automatically cancel it for you. If you have a room reservation
outside of our room block, you will need to take care of that
reservation directly. For those of you that have registered for the
meeting, we will email you shortly regarding it.
Trisha Branan
GSHP President
Summer Meeting 2020
July 10-12, 2020
Omni Amelia Island Resort
Amelia Island, FL
Comments from last year's meeting
GSHP has a superior program! Well worth traveling to attend. Have attended state meetings elsewhere, and Georgia rocks! Very relevant & applicable information, excellent speakers & fun, too.
I thought the meeting was fantastic...the right mix of learning and fun!
Great facility, friendly GSHP facilitators, wonderful learning and collaborative environment
Beautiful location, very good content, will attend again next year
FRIDAY (7 hours) |
|
||
Date/Time |
Topic |
Speaker(s) |
|
8:00am - 9:00am
|
Title: Bridging the gap from hospital to home and the legislative efforts to help improve access to pharmacists outside of the hospital
Objectives: 1. Review what a transition of care program is and the healthcare barriers to a successful transition. 2. Demonstrate the effectiveness of a post discharge medication reconciliation utilizing a clinical pharmacist in the community. 3. Review an example of a transition of care patient case. 4. Discuss pharmacy benefits managers (PBMs) and the role they play in the healthcare system. 5. Identify the barriers brought forth by PBMs and their impact on patient access to care and the negative impact on health outcomes. 6. Discuss legislative efforts in Georgia to help protect patients and improve patient access to pharmacists of their choice. |
Jennifer Shannon, PharmD, BCPS Clinical Pharmacist and Owner Lily's Pharmacy of Johns Creek
|
|
9:00am - 10:00am |
Title: Strengthening strategies against diabetic nephropathy: Role of GLP1-RA and SGLT2 Inhibitors
Objectives: 1. Review the epidemiology and pathophysiology of diabetic nephropathy and list current methods for management. 2. Explain the pharmacological properties of glucagon-like peptide-1 receptor agonists (GLP-1 RA) and sodium-glucose co-transporter 2 inhibitors (SGLT2i) related to improved renal outcomes in people with T2DM. 3. Create an individualized T2DM care plan with focused consideration to renal outcomes.
|
Christina E DeRemer, PharmD, BCPS, BCACP, TTS, FASHP Clinical Associate Professor University of Florida College of Pharmacy
|
|
10:00am - 10:15am |
BREAK |
|
|
10:15am – 11:15am
|
TRACK A
Title: CC - micronutrients v anticoag monitoring?
|
Hal Richards
|
|
TRACK B
|
Courtney Meade
|
||
11:15am – 12:15pm
|
Title: What have you done for me lately?
Objectives: 1. Describe the new Georgia Board of Pharmacy rule updates regarding continuing education for registered and certified pharmacy technicians. 2. Provide an update on the newly proposed Georgia Board of Pharmacy law which must go to the General Assembly regarding the pharmacist to technician ratio. 3. Examine the USP 800 guidelines regarding implementation and evaluation. |
|
|
12:15pm – 12:30pm
|
BREAK |
|
|
12:30pm – 1:30pm
|
Title: Maximizing Opportunities to Protect Vulnerable Adults Against Pneumococcal Disease
Objectives: 1. Describe the clinical consequences of pneumococcal disease and its associated complications among at-risk adults. 2. State the latest ACIP recommendations for pneumococcal vaccination among older adults and other at-risk patient populations. 3. Identify strategies to adhere to ACIP pneumococcal vaccination recommendations and overcome barriers by both healthcare providers and patients.
|
|
|
1:30pm - 2:30 pm |
TRACK A
Title: Meds to Beds Panel Discussion
|
Moderator: Maura Hall
Brittany Wheeler Jameisha Shavers
|
|
TRACK B
Title: Vanc Monitoring
|
Dustin Orvin
|
||
2:30pm – 3:30pm |
Title: ASHP Keynote
Objectives: 1. |
|
|
3:30 pm - 3:45 pm |
BREAK |
|
|
3:45 pm – 5:00 pm |
Officer Installation and Awards
|
|
|
5:00pm – 7:00pm
|
Reception/Exhibits in Exhibit Hall (2 hours) |
------------ |
|
SATURDAY (4 hours) |
|
||
Date/Time |
Topic |
Speaker(s) |
|
(730-930) |
REVERSE EXPO |
|
|
8:00am – 9:00am
|
TRACK A
Title: Advancing Pharmacy-Related Interventions to Control Hypertension and Manage Cholesterol
Objectives: 1. Describe the role of pharmacists in public health. 2. Describe how the I-A-A (identify, assess, act) framework can be used to develop a work plan for creating pharmacy-related interventions. 3. Describe the current initiative(s) of the Georgia Department of Public Health aimed at developing methods to increase pharmacy-related interventions to control hypertension and cholesterol.
|
Gina Ryan, PharmD Chair, Department of Pharmacy Practice Mercer University ryan_gj@mercer.edu
Monyette Childs, MD, MPH Cardiovascular Health Program Manager Georgia Department of Public Health monyette.childs@dph.ga.gov
|
|
TRACK B
Title: CART therapy, including identifying and managing acute and chronic toxicities
|
Amber Clemmons
|
||
9:00am – 11:00am |
Exhibits/Breakfast in Exhibit Area (2 hours) |
|
|
11:00am – 12:00pm
|
Title: ID Jeopardy
Objectives: 1. Recognize guideline directed therapy and monitoring for select disease states. 2. Identify key laboratory values for selecting optimal therapies and monitoring. 3. Distinguish mechanisms of action, safety profile and monitoring parameters for common antimicrobials used in the treatment of infectious diseases. 4. Recall new FDA approved antimicrobials and their uses in therapy. |
Bruce M Jones, Pharm.D., BCPS Infectious Diseases Clinical Pharmacy Specialist St. Joseph's/Candler Health System
Christopher M. Bland, Pharm.D., FCCP, FIDSA, BCPS Clinical Associate Professor UGA College of Pharmacy
|
|
12:00pm – 1:00pm
|
TRACK A
Title: USP <800> The 800lb Gorilla - Standards and Workflows to maintain regulatory compliance
Objectives: 1. Review USP <797> and USP <800> standards and their impact on health systems. 2. Identify the key facility and design requirements for sterile and hazardous drug compounding. 3. Discuss the safe handling and compounding aspects of USP <797> and USP <800> as they relate to the NIOSH hazardous drug list. 4. Describe the implementation of non-facility related workflows. |
Ryan Haumschild, PharmD, MS, MBA Director of Pharmacy Emory University Hospital Midtown
Zachary D. Bush, PharmD, BS Clinical Pharmacy Manager Wellstar Douglas Hospital
|
|
TRACK B
Title: STAR WARS?: Simplifying The Anticoagulation Reversal – Warfarin, Apixaban, Rivaroxaban, otherS (Debate)?
Objectives: 1. Describe pharmacological agents for the reversal of bleeding due to oral anticoagulants (OACs). 2. Discuss laboratory parameters and clinical presentation that aid in determining the degree of anticoagulation while on a OACs. 3. Review cases and discuss management options for the reversal of bleeding due OACs. |
Christopher Morrison, PharmD, BCCCP, FNCS Clinical Pharmacy Specialist - Surgery/Trauma and Medical Critical Care Grady Health System
Sarah Jung, PharmD, MS, BCCCP Neurocritical Care Clinical Pharmacist Wellstar Kennestone Regional Medical Center
|
||
1:00pm - 2:00pm |
Title: Vaping
|
Patrick Filkins, PharmD
|
|
12:00-2:00pm
|
Resident Student Forum |
|
|
SUNDAY (4 hours) |
|
||
Date/Time |
Topic |
Speaker(s) |
|
8:00am – 9:00am
|
Title: Caring for Transplant patients: Implications for Pharmacists
Objectives 1. Review medications commonly prescribed for a patient undergoing transplant (solid organ and bone marrow transplantation). 2. Discuss common adverse events associated with transplant medications. 3. Identify factors that can alter the pharmacokinetics and pharmacodynamics of transplant medications. 4. Given a patient case, apply knowledge to optimize pharmacotherapy regimen for a transplant patient. |
Melissa Laub, PharmD, BCPS Clinical Pharmacist, Solid Organ Transplant Augusta University Medical Center
Arpita Gandhi, Pharm.D., BCOP Hematology/Oncology Clinical Pharmacy Specialist Emory Healthcare
|
|
9:00 am – 10:00 am
|
Title: Emergency response/pandemics
Objectives: 1. |
Trina von Waldner
|
|
10:00 am - 10:15 am |
BREAK |
|
|
10:15 am - 11:15 am
|
Title: Opioid Stewardship
|
Alix Pandolfino
Leslie Roebuck
|
|
11:15 am – 12:15 pm
|
Title: Bridging the Gap with Outpatient Transitions of Care and OPAT Clinics
Objectives: 1. Define TOC and OPAT and describe the overall goals of these clinics. 2. Identify the types of patients appropriate for the TOC and OPAT clinics. 3. Describe the significant impact these clinics have on Grady’s patient population.
|
Becky Andruski, PharmD Ambulatory Care Clinical Pharmacist Grady Health System
|
|
Total available to earn at conference is 15 hours